CY1783A - Hydrogenated 1-benzooxacycloalkyl-pyridine carboxylic-acid compounds - Google Patents

Hydrogenated 1-benzooxacycloalkyl-pyridine carboxylic-acid compounds

Info

Publication number
CY1783A
CY1783A CY178395A CY178395A CY1783A CY 1783 A CY1783 A CY 1783A CY 178395 A CY178395 A CY 178395A CY 178395 A CY178395 A CY 178395A CY 1783 A CY1783 A CY 1783A
Authority
CY
Cyprus
Prior art keywords
denotes
alkylcarbamyl
oxygen atom
optionally
acid compounds
Prior art date
Application number
CY178395A
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of CY1783A publication Critical patent/CY1783A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Novel hydrogenated 1-benzooxacycloalkylpyridinecarboxylic acid compounds of the formula <IMAGE> in which either R1 denotes carboxyl, lower alkoxycarbonyl, carbamyl, N-lower alkylcarbamyl, N,N-dilower alkylcarbamyl or optionally acylated hydroxymethyl and R2 denotes hydrogen, an optionally etherified or acylated hydroxyl group or an optionally acylated amino group or R1 denotes hydrogen and R2 represents carboxyl, lower alkoxycarbonyl, carbamyl, N-lower alkylcarbamyl, N,N-dilower alkylcarbamyl or optionally acylated hydroxymethyl, R3 denotes hydrogen or lower alkyl, alk denotes lower alkylene or lower alkylidene, the ring A is unsubstituted or mono- or polysubstituted by hydroxyl, lower alkoxy, lower alkanoyloxy, halogen, lower alkyl and/or trifluoromethyl, the dashed line is intended to express that a single bond or a double bond is present and either X and Y in each case denotes an oxygen atom and n represents 1 or X represents a methylene group, Y denotes an oxygen atom and n represents 1 or X represents an oxygen atom, Y denotes a methylene group and n represents 1 or X represents a direct bond, Y represents an oxygen atom and n represents 2, and their tautomers and/or salts are described. These compounds can be used as pharmaceutical active substances and can be prepared in a manner known per se.
CY178395A 1986-06-26 1995-10-20 Hydrogenated 1-benzooxacycloalkyl-pyridine carboxylic-acid compounds CY1783A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH258886 1986-06-26

Publications (1)

Publication Number Publication Date
CY1783A true CY1783A (en) 1995-10-20

Family

ID=4237161

Family Applications (1)

Application Number Title Priority Date Filing Date
CY178395A CY1783A (en) 1986-06-26 1995-10-20 Hydrogenated 1-benzooxacycloalkyl-pyridine carboxylic-acid compounds

Country Status (16)

Country Link
EP (1) EP0252005B1 (en)
JP (1) JPH0699420B2 (en)
AT (1) ATE65084T1 (en)
AU (1) AU617988B2 (en)
CA (1) CA1322553C (en)
CY (1) CY1783A (en)
DD (1) DD279674A5 (en)
DE (1) DE3771280D1 (en)
DK (1) DK325587A (en)
ES (1) ES2044970T3 (en)
FI (1) FI91064C (en)
GR (1) GR3002308T3 (en)
HK (1) HK134994A (en)
HU (1) HU207061B (en)
IE (1) IE59881B1 (en)
PT (1) PT85157B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322361A3 (en) * 1987-12-23 1990-01-24 Ciba-Geigy Ag Hydrogenated 1-benzooxacycloalkyl pyridine-carboxylic-acid compounds
US5342616A (en) * 1988-06-20 1994-08-30 The Wellcome Foundation Limited Method of administering tissue plasminogen activator
DE3901814A1 (en) * 1988-07-28 1990-02-01 Bayer Ag SUBSTITUTED AMINOMETHYLZETRALINE AND ITS HETEROCYCLIC ANALOG
ATE121740T1 (en) * 1989-03-22 1995-05-15 Ciba Geigy Ag NEW BENZOTHIOPYRANYLAMINES.
US5189179A (en) * 1990-08-29 1993-02-23 Merrell Dow Pharmaceuticals Inc. Serotonin 5ht1a agonists
US5212170A (en) * 1991-06-21 1993-05-18 American Home Products Corporation Psychotropic piperidinylmethyl benzodioxans
US5221745A (en) * 1991-06-21 1993-06-22 American Home Products Corp. Psychotropic piperidinylmethyl benzodioxans
US5182292A (en) * 1991-06-21 1993-01-26 American Home Products Corporation Psychotropic piperidinylmethyl benzodioxans
US5240943A (en) * 1991-12-19 1993-08-31 G. D. Searle & Co. Benzopyran class iii antiarrhythmic agents
FR2694005B1 (en) * 1992-07-21 1994-08-26 Adir New aminoalkylchromones, methods for their preparation and pharmaceutical compositions containing them.
JP3546657B2 (en) * 1997-08-29 2004-07-28 株式会社トヨトミ Water heater can body structure
WO2006066747A1 (en) * 2004-12-20 2006-06-29 F. Hoffmann-La Roche Ag 4-aminopiperidine derivatives
EP3226851B1 (en) 2014-12-05 2020-03-18 Semmelweis University Arylalkylamine compounds for use in the prevention or treatment of cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1366479A (en) * 1962-08-20 1964-07-10 Res Lab Dr C Janssen Nv Process for the production of novel piperidine derivatives and their salts
GB1520801A (en) * 1975-01-16 1978-08-09 Lafon Labor Benzodioxanyl and benzofuranylmethylamines
AU552050B2 (en) * 1981-05-26 1986-05-22 Smithkline Beckman Corporation N-substituted azeheterocyclic carboxylic acids and their esters
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
FR2524887A1 (en) * 1982-04-08 1983-10-14 Bouchara Emile NOVEL CYANOGUANIDINES, PROCESS FOR OBTAINING THEM AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
DE3411993A1 (en) * 1984-03-31 1985-10-10 Bayer Ag, 5090 Leverkusen SUBSTITUTED BENZOPYRANS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN MEDICINAL PRODUCTS
JPH0816108B2 (en) * 1986-02-21 1996-02-21 株式会社クラレ 3,4-Dihydro-2H-benzopyran derivative and its pharmaceutical use

Also Published As

Publication number Publication date
PT85157A (en) 1987-07-01
IE871694L (en) 1987-12-26
HU207061B (en) 1993-03-01
DK325587D0 (en) 1987-06-25
AU8125587A (en) 1989-05-18
ES2044970T3 (en) 1994-01-16
HUT48622A (en) 1989-06-28
ATE65084T1 (en) 1991-07-15
GR3002308T3 (en) 1992-12-30
FI91064C (en) 1994-05-10
FI91064B (en) 1994-01-31
DE3771280D1 (en) 1991-08-14
EP0252005A1 (en) 1988-01-07
JPS638382A (en) 1988-01-14
HK134994A (en) 1994-12-09
AU617988B2 (en) 1991-12-12
FI872807A (en) 1987-12-27
JPH0699420B2 (en) 1994-12-07
CA1322553C (en) 1993-09-28
IE59881B1 (en) 1994-04-20
DD279674A5 (en) 1990-06-13
DK325587A (en) 1987-12-27
FI872807A0 (en) 1987-06-24
PT85157B (en) 1990-03-30
EP0252005B1 (en) 1991-07-10

Similar Documents

Publication Publication Date Title
CY1783A (en) Hydrogenated 1-benzooxacycloalkyl-pyridine carboxylic-acid compounds
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
MY109345A (en) Improvements in or relating to benzothiophenes.
ATE58292T1 (en) MEDICATION CONTAINING L-DOPA.
HUT38097A (en) Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances
ES8501410A1 (en) Phospholipid derivatives, processes for preparation thereof and pharmaceutical composition of the same.
ES8404850A1 (en) 2-Nitro-ethene diamines, process for their preparation and their use as medicines.
DE3576075D1 (en) 5-ALKYL-1-PHENYL-2-PIPERAZINOALKYLPYRAZOLINE-3-ON COMPOUNDS AND METHODS AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS.
IL85947A (en) 3-(substituted benzyl)-3h- 1,2,3-triazolo (4,5-d) pyrimidine-7-amines, their preparation and pharmaceutical compositions containing them
ES480111A1 (en) Derivatives of 2-imino-imidazolidine, processes for their preparation, pharmaceutical compositions containing them and intermediates.
AU658175B2 (en) Use of 2-iminothiazolidin-4-one derivatives as novel pharmaceutical active ingredients
DK0461574T3 (en) Drugs containing 3,7-diazabicyclo (3,3,1) nonane compounds
GR3007498T3 (en)
ES2001590A6 (en) Hydrogenated pyridine derivatives.
ES464773A1 (en) 2,9-Dioxatricyclo{8 4,3,1,0{hu 3,7{b {9 decane derivatives, processes for their preparation and pharmaceutical compositions thereof
IE791205L (en) Novel oxothia compounds, processes for their preparation,¹pharmaceutical preparations containing these compounds and¹such compounds for therapeutic use
TH2513A (en) Improvements in benzothiazide derivatives. Glycyl cephalosporin or other related
ES8200112A1 (en) Derivatives of clavulanic acid, processes for their preparation and pharmaceutical compositions containing them.